[Quality assurance in head and neck medical oncology].

Abstract:

:In medical oncology, how can we be sure that the right drug is being administered to the right patient at the right time? The implementation of quality assurance criteria is important in medical oncology, in order to ensure that the patient receives the best treatment safely. There is very little literature about quality assurance in medical oncology, as opposed to radiotherapy or cancer surgery. Quality assurance must cover the entire patient care process, from the diagnosis, to the therapeutic decision and drug distribution, including its selection, its preparation and its delivery to the patient (administration and dosage), and finally the potential side effects and their management. The dose-intensity respect is crucial, and its reduction can negatively affect overall survival rates, as shown in breast and testis cancers for example. In head and neck medical oncology, it is essential to respect the few well-standardized recommendations and the dose-intensity, in a population with numerous comorbidities. We will first review quality assurance criteria for the general medical oncology organization and then focus on head and neck medical oncology. We will then describe administration specificities of head and neck treatments (chemoradiation, radiation plus cetuximab, postoperative chemoradiation, induction and palliative chemotherapy) as well as their follow-up. Lastly, we will offer some recommendations to improve quality assurance in head and neck medical oncology.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Digue L,Pedeboscq S

doi

10.1684/bdc.2014.1968

subject

Has Abstract

pub_date

2014-05-01 00:00:00

pages

486-95

issue

5

eissn

0007-4551

issn

1769-6917

pii

bdc.2014.1968

journal_volume

101

pub_type

杂志文章,评审
  • [Angiogenesis targeting in renal carcinomas].

    abstract::Angiogenesis targeting with inhibitors of VEGF receptors is currently modifying in depth the treatment strategy of metastatic clear cell renal carcinoma. Although immunotherapy remains prescribed in selected patients with good prognosis, sunitinib and sorafenib are presently the most active agents in this malignancy. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Pouessel D,Culine S

    更新日期:2007-01-01 00:00:00

  • [Propensity score: interest and limits].

    abstract::Propensity score, an indicator of the propensity to get one treatment among two (or more), is encountered in non randomized studies (prospective or retrospective). It is calculated after the research of predictive factors for treatment attribution, and corresponds to the probability to receive one of the treatments co...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Kwiatkowski F,Slim K,Verrelle P,Chamorey E,Kramar A

    更新日期:2007-07-01 00:00:00

  • [Diagnosis of brain metastases: an update in 2012].

    abstract::Diagnosis of brain metastases should aim to identify anatomoclinical entities for which a specific treatment is more accurate. Growing numbers of targeted therapies have shown to be effective against specific cancers. Several studies have reported that targeted therapies are capable of reducing brain metastases in mel...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1677

    authors: Lechapt-Zalcman E,Karanian-Philippe M,Rousseau A

    更新日期:2013-01-01 00:00:00

  • [COVID-19 impact on the cancer care structuration: Example of the multidisciplinary team meeting dedicated to oncology in Occitanie].

    abstract::This work examines the impact of the SARS-CoV2 epidemic and the organizational recommendations that have been issued since March 16 on tumor boards (TB) activity. The tumor board activity was measured from tumor board sheets extracted from the oncologic electronic file between January 7, 2019 and April 24, 2020. The p...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.05.001

    authors: Grosclaude P,Azria D,Guimbaud R,Thibault S,Daubisse-Marliac L,Cartron G,Renaudie MJ,Dalbies PA,Delord JP,Bauvin E

    更新日期:2020-01-01 00:00:00

  • [The detection of sentinel lymph node in nuclear medicine].

    abstract::The isotopic detection of the sentinel node is undergoing a fast development in breast cancer and melanoma. It requires a good collaboration between a surgeon and a nuclear medicine specialist. Although the method is now well defined for melanoma, several options remain possible for breast cancer. The injected dose an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Maublant J,Cachin F,Mesta D,Geissler B

    更新日期:2002-07-01 00:00:00

  • [Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer].

    abstract::The congress of Asco made the object of numerous summaries of congress made in the heat of the moment and the Bulletin du Cancer decided to ask to his editorial board, a digested summary, at distance of the congress, to try to sum up the data of the congress which are going to change practice. Of the considerable numb...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1221

    authors: André T,Wislez M,Goncalves A,de La Motte Rouge T,Blay JY,Massard C,Bay JO,comité de rédaction du Bulletin du Cancer.

    更新日期:2010-12-01 00:00:00

  • [Uncommon bladder tumours].

    abstract::Bladder tumours are frequent with around 10,000 new cases each year in France. Less than 500 of these cases are not transitional cell carcinoma, the most frequent pathological aspect. The identification of these pathological patterns requires an initial biopsy through transurethral resection. Sarcomatoid, squamous and...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1097

    authors: Boyle H,Fléchon A,Droz JP

    更新日期:2010-01-01 00:00:00

  • [Unresolved questions in the indications for the conservative treatment of invasive cancer of the breast].

    abstract::The majority of patients with breast cancer can be treated by partial mastectomy and radiation therapy. The choice of the treatment involves the estimation of the risk for intramammary recurrence and the ability to achieve satisfactory cosmetic result. Patient selection in breast conserving therapy is dependent on cli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Zinzindohoué C,Bobin JY

    更新日期:1998-09-01 00:00:00

  • [Rare cancers and new radiotherapy techniques].

    abstract::Rare cancers represent about a quarter of all cancers diagnosed in Europe, and their incidence is increasing. Meanwhile, scientific advances provide techniques, which become more and more sophisticated in the domain of radiotherapy. Treatment options for radiotherapy rare cancers are increasing, but are not yet evalua...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2014.12.001

    authors: Espenel S,Trone JC,Vallard A,Guy JB,Moriceau G,Méry B,Langrand-Escure J,Rivoirard R,de Laroche G,Chargari C,Magné N

    更新日期:2015-01-01 00:00:00

  • Herpes virus production as a marker of repair in ultraviolet irradiated human skin cells of different origin.

    abstract::When confluent human skin cultures are ultraviolet (UV)-irradiated before infection with Herpes Simplex type 1 virus (HSV), their capacity to support virus growth is impaired. When the time interval between UV-exposure and infection is increased up to 36 hours, different recoveries of HSV production capacity are obser...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Coppey J,Moreno G,Nocentini S

    更新日期:1978-01-01 00:00:00

  • [New challenge in head and neck oncology surgery: the transoral robotic surgery].

    abstract::Robotic assisted surgery is a new field of developing program for many specialties. As to head and neck oncology, the new procedure potentially offers alternatives to conventional surgery with decreased morbidity. The aim of this article is a description of the state of the art via a review of the literature. We empha...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.1022

    authors: Mallet Y,Moriniere S,Ceruse P,El Bedoui S

    更新日期:2010-01-01 00:00:00

  • [Renal toxicity of contrast agents in oncologic patients].

    abstract::Cancer patients frequently undergo imaging examinations to diagnosis but also to evaluate their responses to treatment. These patients are also at high risk of kidney impairment before considering the possible nephrotoxicity of their chemotherapy. In this context, it is overriding to know contrast agents induced risks...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1477

    authors: Amet S,Deray G

    更新日期:2012-03-01 00:00:00

  • [What are the expectations of coordination and accompaniment of French patients with cancer towards their community pharmacist?]

    abstract:PURPOSES:Analyze the relationship and expectations of cancer patients towards the community pharmacist in a pharmaceutical care coordination project. METHODS:In November 2014, a questionnaire was distributed to ambulatory patients of a university hospital specialized in oncology. Thirteen questions explored the consum...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2017.11.017

    authors: Hébert G,Minvielle E,Di Palma M,Lemare F

    更新日期:2018-03-01 00:00:00

  • [Surgical treatment of carcinomas of the cervix stage III (author's transl)].

    abstract::This study is devoted to the analysis of the surgical treatment of cancer of the uterine cervix, stage III. Three circumstances are evaluated: - Stage III with urinary disease the purpose of the surgical treatment is most often to save the renal function;--Recurrences after radiotherapy where surgery is the only poss...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Rochard F,Michel G,Castaigne D,Lacour J

    更新日期:1980-01-01 00:00:00

  • [Importance of the initial chemotherapy dose in the treatment of small cell lung carcinoma: therapeutic perspectives].

    abstract::Treatment of patients with small-cell lung cancer (SCLC) remains disappointing despite high initial complete response rates. The dramatic initial chemosensitivity of tumor cells is frustrated by the early emergence of chemoresistant clonogenic cells, regardless of front line treatments. Although the dose relationship ...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,meta分析,随机对照试验

    doi:

    authors: Le Chevalier T,Le Cesne A,Arriagada R

    更新日期:1995-01-01 00:00:00

  • [Stakes, aims and specificities of the physician-patient communication in cancer care: state of the art and perspectives].

    abstract::The physician-patient relationship has three main stakes : creating a high-quality inter-personal relationship, exchanging information and decision-making. The achievement of these stakes implies that the physician and the patient are able to reach specific communicational objectives. The aim of this paper is to revie...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Libert Y,Merckaert I,Reynaert C,Razavi D

    更新日期:2006-04-01 00:00:00

  • [The tobacco-cancer problem].

    abstract::Statistical, biological and chemical data on the carcinogenic effect of tobacco smoke are given and are discussed. The epidemiological studies have clearly shown the particularly noxious action of inhalation, and the direct ratio between the risk and the number of cigarettes smoked. The laboratory experiments on biolo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hubert-Habart M

    更新日期:1975-01-01 00:00:00

  • [Bleomycin is an antineoplastic agent capable of mimicking apoptosis].

    abstract::Bleomycin (BLM), a currently used anticancer drug, crosses the plasma membrane poorly. Electropermeabilization allows a defined number of BLM molecules to enter directly into the cell cytoplasm. Such a procedure has revealed that BLM is endowed with a very high intrinsic cytotoxicity. Here we show that when several mi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Tounekti O,Belehradek J Jr,Mir LM

    更新日期:1994-12-01 00:00:00

  • [Cancer of the prostate: estrogen therapy].

    abstract::From 1941, estrogens are usually used in the treatment of prostatic carcinoma, wrongly in case of adjuvant hormonotherapy and exceedingly because of cardiovascular toxicity from over dosages. A recall of their mechanism of action and toxicity allows to argue about the palliative treatment and to look to their use for ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mauriac L,Richaud P,Mage P,Thomas L,Lamarche P

    更新日期:1986-01-01 00:00:00

  • [Specificities of carcinomas in adolescents and young adults].

    abstract::Carcinomas are rare tumors of the adolescent-young adult (AYA) with a different spectrum from those of adults. The most common sites outside of the thyroid is the nasopharynx, salivary gland, colon-rectum and ovaries. If nasopharyngeal carcinoma or salivary gland tumors are good prognosis, others are more reserved pro...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.11.013

    authors: Fresneau B,Dourthe ME,Jouin A,Laurence V,de Lambert G,Colas C,Coret M,Laprie A,Rebours C,Orbach D,Demoor-Goldschmidt C

    更新日期:2017-03-01 00:00:00

  • Mise à jour 2016 des recommandations pour la pratique clinique de Nice/Saint-Paul-de-Vence dans le cancer de l’ovaire et du col de l’utérus à un stade avancé.

    abstract::UPDATED 2016 RECOMMENDATIONS FOR THE CLINICAL PRACTICE OF NICE/SAINT-PAUL-DE-VENCE IN OVARIAN CANCER AND ADVANCED CERVICAL CANCER: Since the first edition of the 2012-2013 Clinical Practice Recommendations Nice-Saint-Paul for gynecological cancers, the management of ovarian cancer has become more complex with a better...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(17)30156-X

    authors: Joly F,Querleu D,Namer M,Pujade-Lauraine E

    更新日期:2017-05-01 00:00:00

  • [What can be now expected of the determination of estrogen and progesterone receptors in the treatment of breast cancers].

    abstract::Since the first published correlations around the years 1975 between estrogen and progesterone receptors and response to hormone therapy, numerous data have modified our insight on hormone dependency. For instance, it is now well established that tumors are not "receptor positive" or "receptor negative" but contain va...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Goussard J,Génot JY

    更新日期:1994-01-01 00:00:00

  • [Secondary non-Hodgkin's lymphomas].

    abstract::Developing a secondary non Hodgkin's lymphoma (NHL) more than 12 months after treatment for first cancer, is uncommon. Secondary NHL occurs sometimes after chronic lymphatic leukemia or Hodgkin's disease. The 20 years cumulative incidence rate is 3-5% after Hodgkin's disease. Secondary NHL seems less frequent after an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Cappelaere P

    更新日期:1998-03-01 00:00:00

  • [Region-wide professional practice evaluation with regards to antiemetic prescription into chemotherapy-induced nausea and vomiting].

    abstract::The anticancer drug technical commission (COTECH) of the Auvergne OMEDIT has set up a region-wide professional practice evaluation (PPE) with regards to antiemetic prescription practices in chemotherapy-induced nausea and vomiting (CINV), in order to evaluate their compliance with OMEDIT's guidelines. Are not included...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.03.009

    authors: Tavernier J,Jouannet-Romaszko M,Bertucat H,Marchiset N,Bahadoor M,Chevrier R

    更新日期:2016-07-01 00:00:00

  • [Docetaxel and gastric cancer].

    abstract::There are very few active drugs in the treatment of metastatic gastric carcinoma. Among new drugs, docetaxel has shown one of the most important activity. With precise evaluation of objective response, this drug has demonstrated a 20% response rate in monotherapy. The favorable toxicity profile of this compound allowe...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Ducreux M,Boige V,Roth A

    更新日期:2004-03-01 00:00:00

  • [Port-site metastases following laparoscopic surgery].

    abstract::Laparoscopy for malignancy resection has been followed by description of metastatic laparoscopic port sites. Recently published clinical, experimental studies and case reports related to this problem are reviewed. Frequency of port-site metastases for gallbladder, colorectal and ovarian cancers seem to differ. Ascites...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Agostini A,Camatte S,Farthouat P,Blanc B,Lecuru F

    更新日期:2000-12-01 00:00:00

  • [Larynx cancer in France: descriptive epidemiology and incidence estimation].

    abstract::The epidemiology of cancers is known in France through mortality data provided by Inserm and morbidity data obtained by French tumor registries. The purpose of this study was to compare the incidence of laryngeal cancers in 9 French departments and to give an estimate of this incidence for the whole of France, based o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Peng J,Ménégoz F,Lesec'h JM,Remontet L,Grosclaude P,Buémi A,Guizard AV,Tretarre B,Danzon A,Velten M,Maarouf N,Jougla E,Launoy G,Dubreuil A

    更新日期:2004-04-01 00:00:00

  • [The management of the metastatic disease by the surgeons].

    abstract::The high rate of recurrence after apparently complete surgery and/or complete clinical response to chemotherapy implies that most patients have undetected minimal residual disease. Novel techniques such as laparoscopic or laparotomic fluorescence may prove to be crucial in reassessing the definition of primary outcome...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2013.1730

    authors: Mery E,Golzio M,Thibault B,Ferron G,Querleu D,Delord JP,Couderc B

    更新日期:2013-04-01 00:00:00

  • [Gene therapy of primary cancers of the liver: hopes and realities].

    abstract::Many efforts have been devoted to the development of gene therapy for primary liver tumors. This has been hampered by the absence of efficient gene transfer vectors for delivering genes into hepatoma cells in vivo. Also it remains to determine which type of gene has to be used to achieve complete tumor regression. Rec...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Ferry N

    更新日期:1997-04-01 00:00:00

  • [Clinical value of the potential doubling time (Tpot) measured by flow cytometry].

    abstract::The potential doubling time (Tpot) is defined as the time necessary to double the number of proliferating tumor cells in the absence of spontaneous cell loss. Tpot is thought to be a better index of tumor proliferation than clinically observed tumour volume doubling time. The in vivo measurement of Tpot is a possible ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Dubray B,Maciorowsky Z,Cosset JM,Terry NH

    更新日期:1995-01-01 00:00:00